Home » Newsletters » BioWorld

BioWorld

May 17, 1993

View Archived Issues

'GENOCULATION' INDUCES IMMUNE RESPONSE

GENZYME SUBSIDIARY FILES FOR IPO

EUROPEAN PANEL RECOMMENDS RECOMBINATE

APPOINTMENTS AND ADVANCEMENTS

UNDERWRITER EXERCISES MOST OF OPTION

EUROPEAN PATENT DISCLOSURES

SPHINX REACQUIRE'S PKC REGULATORS

FDA APPROVES NEOPROBE PHASE III PROTOCOL

PTO ALLOWS PERSEPTIVE PATENT

FDA AFFIRMS SAFE STATUS OF CHYMOGEN

EPO EFFECTIVE AS BLOOD SUPPLEMENT

BTGC MAKES MARKETING PREDICTION

ONCOLOGISTS TO DISCUSS ANTICANCER'S STRATEGY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...